Lantern Pharma Inc.LTRNNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank71
3Y CAGR+37.1%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+37.1%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$526849.00-29.0%
2024$742355.00-3.0%
2023$765388.00+274.5%
2022$204355.00+200.8%
2021$67929.00-
2020$0.00-
2019$0.00-
2018$0.00-